PharmGen Science Inc
KRX:004720
Shareholder Yield
Current shareholder yield for 
PharmGen Science Inc is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
PharmGen Science Inc
| Average Annual Return | -14.68% |
| Standard Deviation of Annual Returns | 25.59% |
| Max Drawdown | -77% |
| Market Capitalization | 87.1B KRW |
| Shares Outstanding | 21 950 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
PharmGen Science Inc's latest stock split occurred on Dec 9, 2014
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, PharmGen Science Inc traded at 362 per share. Afterward, the share price was about 4230.
The adjusted shares began trading on Dec 9, 2014. This was PharmGen Science Inc's 6th stock split, following the previous one in Jul 24, 2012.
